Check out

Thursday, January 30, 2025

FDA Approves Journavx Drug to Treat Pain Without Addiction Risk

The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive.

from NYT > Health https://ift.tt/kKBMCEW

No comments:

Post a Comment

A Newer Kind of Gene Editing Promises to Edit ‘Nurture’ Over ‘Nature’

Traditional gene editing rewrites DNA. But a new approach, called epigenome editing, aims to treat the molecular scars we collect throughout...